Company: SCLXW
Filing Date: 2025-12-11
Form Type: 424B3
Source: 0001193125-25-316258
Chunk: 3

Company: Scilex Holding Co
Filing Date: 2025-12-11
Form: 424B3
Chunk 3
---
 any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 11, 2025 (the “Repricing Date”), Scilex Holding Company (the “Company”) held a special meeting of stockholders (the “Special Meeting”) in a virtual meeting format via live webcast. As further described in Item 5.07 to this Current Report on Form 8-K, at the Special Meeting, the Company’s stockholders approved a one-time repricing (the “Option Repricing”) of certain outstanding stock options granted to, and held by, certain of the Company’s current employees, including its executive officers and named executive officers (namely, Henry Ji, Ph.D., the Company’s Chairperson, Chief Executive Officer and President, and Stephen Ma, the Company’s Chief Financial Officer and Chief Operating Officer), and members of the Board of Directors of the Company (the “Board”) through the Repricing Date (collectively, the “Eligible Participants”), under the Company’s 2022 Equity Incentive Plan, as amended (the “Plan”), that have exercise prices of $282.80 per share, covering up to an aggregate of 289,405 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock” and such options, the “Eligible Options”). The Option Repricing was previously approved by the Board on October 27, 2025, subject to approval by the Company’s stockholders. Effective as of the Repricing Date, the per share exercise price of each Eligible Option held by an Eligible Participant who is an employee of the Company or a member of the Board as of the Repricing Date, as applicable, was automatically reduced to $16.80 per share, which was the closing trading price per share of Common Stock on the Nasdaq Capital Market on the Repricing Date (each, a “Repriced Option”). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options under the Plan, including, without limitation, any provisions with respect to vesting and term of the options, will remain in full force and effect. Item 5.07. Submission of Matters to a Vote of Security Holders. The Special Meeting was held on December 11,